Article : Périodique

Determinants of interest in extended-released buprenorphine: A survey among 366 French patients treated with buprenorphine or methadone

B. ROLLAND ; B. TROJAK ; M. NOURREDINE ; J. BACHELLIER ; M. CHAPPUY ; P. BENDIMERAD ; M. KOSIM ; P. HJELMSTROM ; F. MEROUEH ; P. NUBUKPO ; G. BROUSSE |

Dans Drug and Alcohol Dependence (Vol.220, March 2021)

Aim: To explore the factors determining the interest in extended-release buprenorphine (XR-BUP) injections among patients receiving opioid agonist treatment (OAT) in France. Methods: 366 patients receiving OAT for opioid use disorder, recruited[...]

Plus d'information...

Ajouter au panier

Article : Périodique

What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine

F. VORSPAN ; P. HJELMSTROM ; N. SIMON ; A. BENYAMINA ; A. DERVAUX ; G. BROUSSE ; T. JAMAIN ; M. KOSIM ; B. ROLLAND |

Dans Expert Opinion on Drug Delivery (Vol.16, n°9, 2019)

Introduction: Since the 1990s, opioid maintenance treatments (OMTs), i.e. mostly methadone and buprenorphine, have represented the therapeutic cornerstone of opioid dependence. In France, the public health strategy on opioid dependence, identifi[...]

Plus d'information...

Ajouter au panier

Lien